跳至主要内容
临床试验/IRCT20220112053700N1
IRCT20220112053700N1招募中3 期

The Effect of L-Arginine Supplementation on Hypogonadism in Patients witht Diabetes Type 2.

Arak University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 60 years(—)
性别
Male

入选标准

  • Male Gender
  • Erectile Dysfunction (ED) for at Least 3 Months
  • Having Type 2 Diabetes for at Least a Year
  • Total Testosterone Levels Less than 8 nanomol /Liter or Serum Testosterone in the Range of 8 to 11 nanomol /Liter and Free Testosterone Levels Less than 220 picomoles /Liter
  • Age 40 to 60 Years
  • HBA1C Between 5.5 and 7 (Low and Moderate Risk Diabetes)
  • Do not Take Exogenous Anabolic Steroids

排除标准

  • Patients with Erectile Dysfunction (ED) of known Psychological Origin
  • Patients with Prostate Cancer or Benign Prostatic Hyperplasia
  • Patients with a History of Sleep Apnea
  • Patients with Spinal Cord Injury
  • Patients with known and treated Cardiopulmonary Injury
  • Patients with Hyperthyroidism or Hypothyroidism
  • Patients with known Liver Failure
  • Patients with known Renal Failure
  • Patients with a History of Seizures
  • Patients with known Microvascular Complications of Diabetes (Retinopathy, Neuropathy, Nephropathy
  • Taking Anti-Libido Drugs
  • Taking Antipsychotic or Mood Stabilizing or Antidepressant Medications

研究者

相似试验